Ilia Fishbein

Metalloproteinase inhibitor attenuates neointima formation and constrictive remodeling after angioplasty in rats: augmentative effect of alpha(v)beta(3) receptor blockade.

Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits.

Activated polyurethane modified with latent thiol groups.

Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics.

Study of the drug release mechanism from tyrphostin AG-1295-loaded nanospheres by in situ and external sink methods.

Inhibition of aortic allograft vasculopathy by local delivery of platelet-derived growth factor receptor tyrosine-kinase blocker AG-1295.

The incorporation of an ion channel gene mutation associated with the long QT syndrome (Q9E-hMiRP1) in a plasmid vector for site-specific arrhythmia gene therapy: in vitro and in vivo feasibility studies.

Systemic depletion of macrophages by liposomal bisphosphonates reduces neointimal formation following balloon-injury in the rat carotid artery.

Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries.

Site specific gene delivery in the cardiovascular system.

Bisphosphonate-mediated gene vector delivery from the metal surfaces of stents.

Adenoviral gene vector tethering to nanoparticle surfaces results in receptor-independent cell entry and increased transgene expression.

High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents.

Local delivery of gene vectors from bare-metal stents by use of a biodegradable synthetic complex inhibits in-stent restenosis in rat carotid arteries.

Magnetically responsive biodegradable nanoparticles enhance adenoviral gene transfer in cultured smooth muscle and endothelial cells.

Analytical chemistry: The matrix neutralized.

Site-specific gene therapy for cardiovascular disease.

Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields.

Magnetic nanoparticles for targeted vascular delivery.

Formulation and in vitro characterization of composite biodegradable magnetic nanoparticles for magnetically guided cell delivery.

Magnetically targeted delivery of therapeutic agents to injured blood vessels for prevention of in-stent restenosis.

Site-specific gene delivery to stented arteries using magnetically guided zinc oleate-based nanoparticles loaded with adenoviral vectors.

Anchoring of self-assembled plasmid DNA/anti-DNA antibody/cationic lipid micelles on bisphosphonate-modified stent for cardiovascular gene delivery.

Adenoviral vector tethering to metal surfaces via hydrolyzable cross-linkers for the modulation of vector release and transduction.

Modulation of NO and ROS production by AdiNOS transduced vascular cells through supplementation with L-Arg and BH4: implications for gene therapy of restenosis.

Real-time analysis of composite magnetic nanoparticle disassembly in vascular cells and biomimetic media.

Nanoparticle-mediated delivery of a rapidly activatable prodrug of SN-38 for neuroblastoma therapy.

Endovascular Gene Delivery from a Stent Platform: Gene- Eluting Stents.

Magnetically enhanced cell delivery for accelerating recovery of the endothelium in injured arteries.

Enhanced biocompatibility of CD47-functionalized vascular stents.

Paraffin processing of stented arteries using a postfixation dissolution of metallic and polymeric stents.

Optimizing endothelial cell functionalization for cell therapy of vascular proliferative disease using a direct contact co-culture system.

Stability and bioactivity of pepCD47 attachment on stainless steel surfaces.

Experimental Single-Platform Approach to Enhance the Functionalization of Magnetically Targetable Cells.